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Abstract
Introduction: We previously reported that sialyl Lewisy, synthesized by fucosyltransferases, is involved in
angiogenesis. Fucosyltransferase 1 (fut1) is an α(1,2)-fucosyltransferase responsible for synthesis of the H blood
group and Lewisy antigens. However, the angiogenic involvement of fut 1 in the pathogenesis of rheumatoid
arthritis synovial tissue (RA ST) has not been clearly defined.
Methods: Assay of α(1,2)-linked fucosylated proteins in RA was performed by enzyme-linked lectin assay. Fut1
expression was determined in RA ST samples by immunohistological staining. We performed angiogenic Matrigel
assays using a co-culture system of human dermal microvascular endothelial cells (HMVECs) and fut1 small
interfering RNA (siRNA) transfected RA synovial fibroblasts. To determine if fut1 played a role in leukocyte retention
and cell proliferation in the RA synovium, myeloid THP-1 cell adhesion assays and fut1 siRNA transfected RA synovial
fibroblast proliferation assays were performed.
Results: Total α(1,2)-linked fucosylated proteins in RA ST were significantly higher compared to normal (NL) ST. Fut1
expression on RA ST lining cells positively correlated with ST inflammation. HMVECs from a co-culture system with
fut1 siRNA transfected RA synovial fibroblasts exhibited decreased endothelial cell tube formation compared to
control siRNA transfected RA synovial fibroblasts. Fut1 siRNA also inhibited myeloid THP-1 adhesion to RA synovial
fibroblasts and RA synovial fibroblast proliferation.
Conclusions: These data show that α(1,2)-linked fucosylated proteins are upregulated in RA ST compared to NL ST.
We also show that fut1 in RA synovial fibroblasts is important in angiogenesis, leukocyte-synovial fibroblast
adhesion, and synovial fibroblast proliferation, all key processes in the pathogenesis of RA.
Introduction
The pathogenesis of rheumatoid arthritis (RA) is charac-
terized by the infiltration of inflammatory cells into the
pannus, followed by tissue destruction. The RA syno-
vium contains elevated levels of cytokines and inflam-
matory cells such as lymphocytes and monocytes [1,2].
Chemokines and other inflammatory mediators drive the
pathogenesis of RA and regulated production of proin-
flammatory cytokines is important for the orchestration
of the inflammatory response [3-5]. Current therapies
are designed to block cytokines such as TNF-α or IL-6
[6,7]. However, despite the success of blocking these
cytokines, not all RA patients respond adequately to
anti-TNF-α or anti-IL-6 therapy.
Angiogenesis is a highly regulated process that results
in the formation of new vessels. It is important in vascu-
loproliferative states such as wound repair and chronic
inflammation, as seen in RA [8,9]. The angiogenic
process is important in the progression of RA and may
prove to be a promising therapeutic target [10]. Cellular
adhesion molecules expressed on endothelial cells (ECs)
are involved in leukocyte extravasation into the syno-
vium leading to perpetuation of RA synovial inflam-
mation [11].
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Glycosylation is one of the most common posttran-
slational modification reactions, and many proteins in
eukaryotes are glycosylated [12]. Most of these are
N-linked and/or O-linked glycan chains that are synthe-
sized posttranslationally in the endoplasmic reticulum and
the Golgi apparatus by various glycosyltransferases [13].
Fucosylated glycans are synthesized by fucosyltransferases
(futs). Thirteen fut genes have been identified in the
human genome [14]. Fucosyltransferase 1 (fut1) and fut2
are α(1,2)-fucosyltransferases responsible for synthesis of
the H blood group antigen and related structures [15,16].
Fut1 is overexpressed in some cancers such as colon and
pancreas [17,18]. These reports indicate that α(1,2)-linked
fucose synthesized by futs are important for tumor
growth. In regards to arthritis, mRNA levels of fut7 are
upregulated in synovial fluid (SF) compared to peri-
pheral blood T cells in patients with juvenile idiopathic
arthritis [19].
We have shown previously that the soluble form of
E-selectin mediates angiogenesis via its endothelial lig-
and sialyl Lewisx [20]. We have also shown that Lewisy-
6/H/5-2 (Ley/H), synthesized by fut1, and its glucose
analog, 2-fucosyllactose (H-2 g) mediates angiogenesis
and inflammatory cell adhesion [21,22]. However, a
direct role for fut1 in RA has not been demonstrated. In
this study, we found that α(1,2)-linked fucosylated pro-
teins were expressed in RA synovium. Hence, we show
that α(1,2)-linked fucosylated proteins are upregulated in
RA synovial tissue (ST) and that fut1 in RA synovial
fibroblasts is important in EC tube formation, leukocyte-
synovial fibroblast adhesion, and synovial fibroblast pro-
liferation, all critical aspects of inflammation in the RA
joint synovium.
Methods
Patients
RA and osteoarthritis (OA) ST were obtained from pa-
tients undergoing arthroplasty or synovectomy. Normal
(NL) ST samples were obtained from a National Disease
Research Interchange and Cooperative Human Tissue
Network. NL skin biopsies were obtained from the
University of Michigan Tissue Procurement Service. For
all human specimens used in this study, we obtained
written informed consent with approval from the
University of Michigan Institutional Review Board.
Homogenate preparation
ST homogenates were prepared in anti-protease buffer
as we have done previously [23]. Briefly, RA, OA and
NL STs were homogenized in 5 ml of a 1% protease
inhibitor cocktail (Pierce, Rockford, IL, USA) in PBS.
Samples were centrifuged at 900 g for 10 minutes, and
filtered through a 1.2-μm pore size Sterile Acrodisk, and
frozen at −80°C until thawed for assay. The total protein
concentration of each lysate was determined using a
bicinchoninic acid assay (Pierce).
Cell culture
Fresh STs were minced and digested in tissue enzyme
digestion solution as described previously [24]. The
synovial fibroblasts were maintained in Roswell Park
Memorial Institute (RPMI) 1640 medium supplemented
with 10% FBS. Cells were seeded in 6-well plates (BD
Biosciences, Bedford, MA, USA) at a density of 1 × 105
cells per well, and were maintained in complete medium.
After overnight serum starvation, cells were treated with
25 ng/ml TNF-α (R&D Systems, Minneapolis, MN,
USA) for 24 hours. Cell-conditioned medium and cell
lysates were collected. We used fibroblasts from three
NL knees; three knees and one hip from OA patients;
and six knees from RA patients.
Human dermal microvascular endothelial cells (HMVECs)
were purified from digested skin biopsies using mouse anti-
human CD31 MicroBeads (Miltenyi Biotec, Cambridge,
MA, USA), according to the manufacturer’s protocol. Cells
were cultured in EC basal medium (Lonza, Walkersville,
MD, USA) with growth factors. In order to confirm EC
purity, we used antibodies to EC markers von Willebrand
factor and CD31 and immunohistochemistry. THP-1 cells
(human acute monocytic leukemia cell line) were
purchased from the American Type Culture Collection
(Manassas, VA, USA). THP-1 cells were cultured in RPMI
supplemented with 10% FBS.
Enzyme-linked lectin assay (ELLA)
For RA, OA and NL ST homogenate analysis, we mea-
sured the total protein content of each of our samples as
done previously [25]. We next used Ulex Europeaus
Agglutinin 1 lectin (UEA-1) to measure α(1,2)-linked
fucosylated proteins in the same samples. UEA-1 binds
specifically to α(1,2)-fucose, the terminal sugar of blood
group antigens H and Lewisy. 2′fucosyllactose-bovine
serum albumin (2′FL-BSA), 50 to 0.78 ng/ml (V-labs
Inc, Covington, LA, USA) was used as a standard for
measurement of total fucosyated proteins. Because 2′FL-
BSA is linked to α(1,2)-fucose on BSA, and BSA is a well
known standard for measuring proteins, we used 2′FL-
BSA as a metric for quantifying total α(1,2)-linked fuco-
sylated proteins in our samples. Results are presented as
the ratio of the total fucosylated proteins in each of the
ST homogenate samples using fucosylated BSA as stan-
dard (in ng of 2′FL-BSA), normalized to the total pro-
tein content of the same sample (in mg) as measured
using nonfucosylated BSA as a standard (Pierce).
The ELLA was performed by adding samples and stan-
dards to 96-well plates with an overnight incubation at
4°C. The next day, plates were washed (PBS + 0.05%
Tween), and blocked with Synblock (ImmunoChemistry
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Tech, Bloomington, MN, USA) for 2 hours. UEA-1,
2 μg/ml (Vector laboratories Inc, Burlingame, CA, USA)
was added for 90 minutes followed by 10 μg/ml biotiny-
lated goat anti-UEA-1 antibody (Vector laboratories Inc)
for 60 minutes, then streptavidin-horseradish peroxidase
(HRP) for 30 minutes. Tetramethylbenzine substrate
(TMB) was used as a color development reagent and the
plate was read at 450 nm following addition of 1 N
H2SO4 on a BioTek Synergy plate reader (Winooski, VT,
USA). Total fucosylated proteins from synovial fibroblast
conditioned medium and cell lysates were measured by
ELLA using 2′FL-BSA as a standard curve.
Immunofluorescence
Immunofluorescence staining on RA ST fibroblasts was
performed as previously described [25]. To determine if
α(1,2)-linked proteins were expressed on RA ST syno-
vial fibroblasts, mouse anti-human collagen-1 (Abcam,
Cambridge, MA, USA) and goat anti-UEA-1 (Vector
laboratories Inc.) were used. RA ST slides were fixed with
cold acetone for 20 minutes. Then slides were blocked with
20% FBS and 5% donkey serum for 1 hour at 37°C, and in-
cubated with UEA-1 (2 μg/ml, Vector laboratories Inc.) for
1 hour at 37°C. Goat anti-UEA-1 and rabbit anti-human
collagen-1 were used as primary antibodies. Fluorescent
conjugated donkey anti-goat (for UEA-1) and anti-mouse
(for collagen-1) secondary antibodies were purchased from
Life Technologies (Carlsbad, CA, USA). For nuclear
staining, 4′, 6-diamidino-2-phenylindole (DAPI) was used.
Images were taken at 100× magnification. Anti-collagen-1-
positive fibroblasts were shown by fluorescent red staining,
and fucosylation was shown by fluorescent green. Yellow
cells were a result of merging the green and red fields.
Dual immunofluorescence staining was done on RA ST
sections embedded in optimal cutting temperature (OCT)
medium and cryosectioned. The slides were fixed and
blocked in 5% goat serum. Rabbit anti-human fut1 (Thermo
Scientific, Waltham, MA), mouse anti-human CD68 macro-
phage marker (BD Biosciences, San Jose, CA), and mouse
anti-human Cadherin-11 (fibroblast marker; R&D Systems)
were used as primary antibodies at a concentration of
10 μg/ml and incubated for 1 hour at 37°C. The slides were
washed with PBS and goat anti-rabbit fluorescein
isothiocyanate (FITC)-conjugated and goat anti-mouse
rhodamine-conjugated antibodies were used as secondary
antibodies and were incubated for 1 hour at 37°C. The slides
were again washed in PBS and 4′, 6-diamidino-2-phenylin-
dole (DAPI) staining was used at 1:5,000 concentration. The
slides were mounted and visualized under tetramethylrho-
damine (TRITC), FITC, and DAPI wavelengths.
Immunohistologic analysis
We performed immunoperoxidase staining on cryosec-
tions from NL, OA, and RA ST as described previously
[25]. ST samples were blocked with 20% FBS and 5%
goat serum in PBS, and incubated with mouse anti-
human fut1 (10 μg/ml, Thermo Scientific) or purified
nonspecific mouse IgG. ST samples were washed with
PBS, and a 1:200 dilution of biotinylated goat anti-
mouse antibody was added. After washing, antibody
binding was detected using a Vectastain ABC Elite per-
oxidase system (Vector laboratories Inc.) and chromogen
3,3′-diaminobenzidine (DAB) (Kirkegaard & Perry
Laboratories Inc., Gaithersburg, MD, USA). ST samples
were counterstained with Harris hematoxylin. Staining
was evaluated by a pathologist blinded to the experimen-
tal conditions. Each of the ST components was graded
for immunostaining and scored 0% to 100%, in which
0% indicates no staining and 100% indicates that all cells
were immunoreactive [25].
Transfection of RA synovial fibroblasts with fut1 small
interfering RNA (siRNA)
RA synovial fibroblasts were seeded in 6-well plates at a
density of 1 × 105 cells per well. Cells were maintained in
complete medium up to 70% confluency. siRNA (50 nM)
against fut1 or control siRNA and transfection regent
(Mirus, Madison, WI, USA) was mixed with TransIT-TKO
transfection reagent according to manufacturer’s instruc-
tions and overlaid on the cells. Cells were incubated with
the siRNA/TransIT-TKO for 24 hours at 37°C. Control and
fut1 siRNA were purchased from Santa Cruz Biotechnology.
To determine the transfection efficiency of cells, a
fluorescein-conjugated nonsilencing siRNA (Santa Cruz
Biotechnology) was transfected into cells with TransIT-
TKO. Transfected cells were counted by fluorescence
microscopy, and total cells were counted by bright field
microscopy. The transfection efficiency was calculated as
the percent of fluorescein-positive cells divided by the
number of bright field cells. The percent knockdown of
fut1 expression was confirmed using quantitative poly-
merase chain reaction (qPCR) and western blotting.
Cell lysis and western blotting
Cell lysis and western blotting were performed as pre-
viously described [25]. RA synovial fibroblasts were
transfected with fut1 siRNA or control siRNA. Cells
were seeded in 6-well plates at a density of 1 × 105 cells
per well. After overnight serum starvation, cells were
stimulated with TNF-α (25 ng/ml). Membranes were
probed with rabbit anti-human fut1 antibody (Epitomics
Inc., Burlingame, CA, USA). The immunoblots were
stripped and reprobed with rabbit anti-β-actin to verify
equal loading. For cell signaling experiments, antibodies
against phosphorylated and total JNK, NFκB, P38, and
Erk1/2 (Cell Signaling Technology, Danvers, MA, USA)
were used.
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Co-culturing HMVECs and RA synovial fibroblasts in the
EC tube formation assay
In order to confirm the effect of fut1 on HMVEC tube for-
mation, a facet of angiogenesis, we co-cultured HMVECs
and RA synovial fibroblasts using a Costar transwell
system (Corning Inc., Lowell, MA, USA). RA synovial
fibroblasts were first transfected with either control or
fut1 siRNA as described above and were plated in the top
inserts of the transwell system. HMVECs were grown on
the bottom wells. HMVECs and RA synovial fibroblasts
were co-cultured with serum-free endothelial basal
medium (EBM) for 24 hours. HMVECs were collected
from the co-culture plates, and subsequently plated on
Matrigel (BD Biosciences) with the co-cultured con-
ditioned media for 6 hours at 37°C. Tubes formed by
HMVECs were counted by a blinded observer [26].
RNA extraction and qPCR of RA synovial fibroblasts
RNA extraction and qPCR were performed as previously
described [27]. Fut1, monocyte chemoattractant protein 1
(MCP-1)/CCL2, epithelial-derived neutrophil-activating
peptide 78 (ENA-78)/CXCL5, vascular endothelial growth
factor (VEGF) and β-actin primer pairs were purchased
from Integrated DNA Technologies (Coralville, IA, USA).
The following primers were used; fut1 forward 5′-GTG
CCCGTATCCAGAGTGAT-3′; reverse 5′-AGGACCCA
GGGGAGAGTAAA-3′; MCP-1/CCL2 forward 5′-TCC
AGCATGAAAGTCTCTGC-3′; reverse 5′-TGGAATC
CTGAACCCACTTC-3′; ENA-78/CXCL5 forward 5′-GA
GAGCTGCGTTGCGTTTG-3′; reverse 5′-TTTCCTTG
TTTCCACCGTCCA-3′; VEGF forward 5′-ATGAACTT
TCTGCTGTCTTGGGT-3′; reverse 5′-TGGCCTTGG
TGAGGTTTGATCC-3′; β-actin forward 5′-GCTAGGC
AGCTCGTAGCTCT-3′; reverse 5′-GCCATGTACGT
TGCTATCCA-3′. All samples were run in duplicate
and analyzed using Applied Biosystems software (Life
Technologies).
ELISA for MCP-1/CCL2, ENA-78/CXCL5, and VEGF
ELISA was performed in a manner described previously
[28]. Fut1 siRNA, control siRNA or nontreated RA syn-
ovial fibroblasts were stimulated with TNF-α (25 ng/ml)
for 24 hours, and cell supernatants were collected.
Levels of MCP-1/CCL2, ENA-78/CXCL5, and VEGF
were measured.
In vitro cell adhesion assay
Adhesion of THP-1 cells to nontreated, control siRNA
or fut1 siRNA treated RA synovial fibroblasts grown to
confluence in 96-well plates was examined [25]. RA syn-
ovial fibroblasts were serum-starved overnight. The next
day, cells were treated with TNF-α (25 ng/ml) for
24 hours. THP-1 cells were collected and labeled with
5 μM Calcein AM fluorescent dye (Life Technologies)
for 30 minutes. After washing twice, 1 × 105 THP-1 cells
were added to each well and incubated for 30 minutes at
room temperature. Nonadherent cells were washed off and
fluorescence was measured using a Synergy HT fluores-
cence plate reader (BioTek Instruments, Winooski, VT).
Cell surface ELISA for adhesion molecule expression
Nontreated, control siRNA-transfected, or fut1 siRNA-
transfected RA synovial fibroblasts (1 × 105/well) were
seeded in 96-well plates. Confluent RA synovial fibro-
blasts were serum-starved overnight prior to stimulation
with TNF-α (25 ng/ml) for 24 hours. Cells were fixed
with 3.7% formalin in PBS, and cell surface ELISA was
performed as previously described [29]. Mouse anti-
human antibodies specific for intercellular adhesion
molecule 1 (ICAM-1), 10 μg/ml, (R&D Systems) or vas-
cular cell adhesion molecule 1 (VCAM-1) were used,
and the plates were read with an ELISA reader at
450 nm.
Cell proliferation assay
Control or fut1 siRNA-transfected RA synovial fibro-
blasts were seeded in 96-well plates at 5 × 104 cells/ml.
Cells were serum-starved overnight then treated with
10 μg/ml lipopolysaccharide (LPS) from Escherichium
coli 0111 (Sigma-Aldrich) for 4 and 24 hours. Each treat-
ment group experiment was performed in four replicate
wells. DNA was measured using a CyQuant cell prolifer-
ation assay kit (Life Technologies) following the manu-
facturer’s instructions. For the assay, cells were lysed and
total cellular nucleic acid was measured using fluores-
cence at 520 nm emission after excitation at 480 nm.
Statistical analysis
All data were analyzed using parametric tests, namely
the Student’s t-test assuming equal variances. Data are
reported as the mean ± standard error of the mean
(SEM). P-values less than 0.05 were considered statisti-
cally significant. All error bars represent the SEM and n
represents the number of independent experiments. Of
note, all data represented in the manuscript that were
significant using a parametric test, were similarly signifi-
cant using the one-tailed Mann Whitney test.
Results
α(1,2)-linked fucosylated proteins are expressed in RA ST
We hypothesized that α(1,2)-linked fucosylated proteins
are important in RA inflammation and play a role in
angiogenesis, cell adhesion, and cell proliferation. To test
this hypothesis, we determined whether α(1,2)-linked
fucosylated proteins in RA synovium were higher than
in other synovia. We found that RA ST homogenates
contained significantly more fucosylated proteins than
did either OA or NL STs (Figure 1A).
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In order to determine the location of α(1,2)-linked fuco-
sylated proteins expressed within the ST samples, we per-
formed immunofluorescence staining. We found that
α(1,2)-linked fucosylated proteins were expressed on RA
ST fibroblasts (Figure 1B). In addition, we found that
α(1,2)-linked fucosylated proteins in RA synovial fibroblast-
conditioned medium and cell lysates (30 ± 2 ng/ml of 2′FL-
BSA and 1485 ± 204 ng/ml of 2′FL-BSA, respectively) were
significantly higher compared to NL synovial fibroblasts
(16 ± 1 ng/ml of 2′FL-BSA and 847 ± 159 ng/ml of 2′FL-
BSA, respectively (Figure 1C and D).
Fut1 is expressed on RA ST lining cells, fibroblasts and
macrophages
We determined whether fut1 was present in STs.
Figures 2A and B show a photomicrograph using anti-
fut1 (Figure 2A) or non-specific IgG (Figure 2B). The
photomicrograph shown is from an RA ST showing
60%-positive lining cell staining, with the lining layer be-
ing composed of macrophages and fibroblasts. RA STs
contained a greater percentage of fut1 positive lining
cells than did OA or NL STs; mean number of lining
cells ± SEM; RA ST (n = 26) 13 ± 3%; OA ST (n = 22)
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Figure 1 α(1,2)-linked fucosylated proteins are expressed in rheumatoid arthritis (RA). (A) RA synovial tissue (ST) homogenates contained
more α(1,2)-linked fucosylated proteins than did osteoarthritis (OA) or normal (NL) STs (normalized to total protein concentration). Results are
expressed as a ratio of the amount of fucosylated BSA/total proteins in the ST homogenates using BSA as a standard. (B) Photographs of RA ST. The
far left panel shows staining with mouse anti-collagen 1. The middle panel shows staining with Ulex Europeaus Agglutinin 1 lectin (UEA-1) and goat
anti-UEA-1. The right panel shows merging of the left panel and middle panel. Yellow indicates α(1,2)-linked fucosylated proteins associated with RA
ST fibroblasts and the blue indicates DAPI staining of the tissue (original magnification 100×). (C) α(1,2)-linked fucosylated proteins in RA synovial
fibroblast-conditioned medium were significantly higher than in OA and NL synovial fibroblast-conditioned medium. (D) α(1,2)-linked fucosylated
proteins in RA synovial fibroblast cell lysates were significantly higher than in NL synovial fibroblast cultures: 2′fucosyllactose-bovine serum albumin
(2′FL-BSA) was used as a standard.
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Figure 2 Immunohistologic analysis of fucosyltransferase 1 (fut1) expression. (A and B) Photomicrographs of ST samples from patients with
rheumatoid arthritis (RA). Cryosections were stained with anti-fut1 (A) or control IgG (B). Original magnification is 400×. Arrows indicate fut1 expression. RA
synovial tissues (STs) contain a greater percentage of fut1 lining cells (C) compared to OA and NL ST. A significantly elevated percentage of macrophage
staining on RA compared to OA or NL STs was also found (D). Expression of fut1 mRNA in TNF-α stimulated or nonstimulated RA synovial fibroblasts was
significantly elevated compared to TNF-α stimulated or nonstimulated NL synovial fibroblasts (E). Means are presented with standard error. *P <0.05 was
significant. NS = nonstimulated. (n = number of RA patients or patient ST fibroblasts). (F) Left panel, fut1 straining in RA ST (green); middle panel,
cadherin-11 staining in RA ST (red); right panel, merge of the previous two figures. The arrow indicates fut1 and cadherin-11-positive cells respectively
(yellow), indicating that fut1 is expressed on fibroblasts in RA ST. (G) Left panel, fut1 straining in RA ST (green); middle panel, CD68 staining in RA ST
(red); right panel, merge of the previous two panels. The arrows indicate fut1 on CD68-positive cells, validating that fut1 is expressed on macrophages
in RA ST (yellow). The blue background is 4′,6-diamidino-2-phenylindole (DAPI) staining. IgG control staining was performed and showed no
fluorescence staining (data not shown; all figures are 400× magnification).
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3 ± 1% and NL ST (n = 18) 0 ± 0%, P <0.05 between RA
and OA ST; RA and NL ST (Figure 2C). We found ECs
expressing fut1 in RA, OA and NL ST, although the per-
centage of positive fut1 staining on ECs was relatively
low for all groups (<2%). We also found that RA STs
contained a greater percentage of fut1-positive synovial
macrophages than did OA or NL STs; mean number of
synovial macrophages ± SEM; RA ST (n = 26) 17 ± 2%;
OA ST (n = 22) 6 ± 2% and NL ST (n = 18) 2 ± 1%,
P <0.05 between RA and OA ST; RA and NL ST
(Figure 2D).
In addition, to determine whether fut1 was expressed
in RA synovial fibroblasts, qPCR was performed. We
found that expression of fut1 mRNA in nonstimulated
RA synovial fibroblasts was significantly higher than in
nonstimulated NL synovial fibroblasts (3.5 ± 0.7 fold in-
creased (Figure 2E). Expression of fut1 mRNA in TNF-α
stimulated RA synovial fibroblasts was also significantly
elevated compared to that in TNF-α stimulated NL syn-
ovial fibroblasts (4.6 ± 0.8-fold increased). To further
validate and distinguish cellular fut1 staining in RA ST,
we performed dual immunofluorescence staining on RA
ST fibroblasts and macrophages. In Figure 2F, the left
panel is fut1 staining in RA ST (green). The middle
panel is cadherin-11 (fibroblast marker) staining in RA
ST (red). The right panel is the merge of the previous
two panels. The arrow indicates fut1- and cadherin-11-
positive cells respectively (yellow), indicating that fut1 is
expressed on fibroblasts in RA ST. In Figure 2G, the left
panel is fut1 staining in RA ST (green). The middle
panel is CD68 (macrophage marker) staining in RA ST
(red). The right panel is the merge of these two panels.
The arrows indicate fut1 on CD68-positive cells (yellow),
indicating that fut1 is expressed on macrophages in RA
ST. The blue background is DAPI staining. IgG control
staining was performed and showed no fluorescence
staining.
Blocking fut1 expression in RA synovial fibroblasts
reduces EC tube formation
To determine the function of fut1 in RA synovial fibro-
blasts, we used siRNA directed against fut1. The trans-
fection efficiency in RA synovial fibroblasts was 88 ± 2%
(n = 4 patients), and the percent knockdown of fut1
mRNA was 73 ± 1% (n = 4 patients). The specific knock-
down of fut1 was confirmed by western blotting, and
fut1 protein levels were decreased (Figure 3A). To exam-
ine the role of fut1 in angiogenesis with respect to RA,
we co-cultured HMVECs with nontreated, control
siRNA or fut1 siRNA-transfected RA synovial fibroblasts
in an in vitro chamber system. HMVECs harvested from
the fut1 siRNA-transfected RA synovial fibroblast co-
culture system had decreased EC tube formation com-
pared with HMVECs harvested from the control siRNA
or the nontreated RA synovial fibroblast co-culture
system (number of EC tubes formed per high power
field ± SEM; 4 ± 2, 23 ± 1 and 27 ± 1, respectively;
P < 0.05, Figure 3B and C).
Blocking fut1 expression in RA synovial fibroblasts
reduces expression of proangiogenic mediators
We found that mRNA expression of MCP-1/CCL2,
ENA-78/CXCL5 and VEGF in TNF-α-stimulated fut1
siRNA-transfected RA synovial fibroblasts was signifi-
cantly decreased compared to control siRNA-transfected
RA synovial fibroblasts (Figure 4A, B and C). Hence, we
measured secretion of MCP-1/CCL2, ENA-78/CXCL5
and VEGF in fut1 or control siRNA-transfected and
nontreated RA synovial fibroblast-conditioned medium.
The secretion of MCP-1/CCL2, ENA-78/CXCL5, and
VEGF in TNF-α-stimulated fut1 siRNA-transfected RA
synovial fibroblasts was significantly decreased com-
pared with control siRNA-transfected or nontreated RA
synovial fibroblasts (Figure 4D, E and F).
Fut1 siRNA inhibits THP-1 cell adhesion to RA synovial
fibroblasts
To determine if fut1 mediates leukocyte adhesion to RA
synovial fibroblasts, we performed in vitro adhesion assays.
We found that adhesion of THP-1 cells to fut1 siRNA-
transfected RA synovial fibroblasts in response to TNF-α
was significantly decreased compared with that to control
siRNA transfected or nontreated RA synovial fibroblasts
(Figure 5A). In addition, we performed a cell-surface
ELISA to determine if cell adhesion molecules were de-
creased on the cell surface of fut1 siRNA-transfected RA
synovial fibroblasts. We found that ICAM-1 and VCAM-1
on TNF-α-stimulated fut1 siRNA-transfected RA synovial
fibroblasts were decreased compared to control siRNA-
transfected or nontreated RA synovial fibroblasts (Figure 5B
and C). These results confirm that fut1 inhibition regulates
TNF-α-induced fibroblast adhesion and adhesion molecule
expression.
Fut1 siRNA inhibits RA synovial fibroblast proliferation
The effect of fut1 on RA synovial fibroblast proliferation
was examined. We found that RA synovial fibroblasts
transfected with fut1 siRNA showed less proliferation in
response to LPS at 4 and 24 hours (Figure 5D).] As
shown in Figure 5D, fut1 siRNA-transfected LPS-
stimulated RA synovial fibroblast cultures displayed sig-
nificantly less proliferation at 4 and 24 hours compared
to LPS-stimulated control siRNA-transfected or non-
treated RA synovial fibroblasts. These results show that
fut1 inhibition decreases fibroblast proliferation in re-
sponse to LPS stimulation.
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Fut1 siRNA inhibits phosphorylated JNK signaling in RA
synovial fibroblasts
To determine RA synovial fibroblast fut1-associated sig-
naling mechanisms, western blot was performed using
fut1 or control siRNA-transfected RA synovial fibroblasts
stimulated with TNF-α (25 ng/ml) for 10 and 30 minutes.
We found that phosphorylated JNK signaling in TNF-α-
stimulated fut1 siRNA-transfected RA synovial fibroblasts
was significantly decreased at 10 minutes compared to
control siRNA-transfected cells (Figure 6A). However,
phosphorylated NFκB, P38, and Erk1/2 signaling were not
different between fut1- and control siRNA-transfected RA
synovial fibroblasts (Figure 6B). These results indicate that
early phosphorylation of JNK is important for fut1 signa-
ling in RA synovial fibroblasts.
Discussion
Posttranslational modifications, such as glycosylation,
citrullination or NH2-terminal truncation of natural cyto-
kines, change their biological activity [30,31]. Nabeshima
et al. reported that the cytokine glycosylation on receptor
binding changed biological activity [32]. These reports
indicate that glycosylated cytokines may contribute to
disease pathogenesis. Over half of known proteins are
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Figure 3 Fucosyltransferase 1 (fut1) expression was decreased using siRNA against fut1 in rheumatoid arthritis (RA) synovial
fibroblasts. Cells were stimulated with TNF-α (25 ng/ml) for 24 hours. (A) Fut1 expression in fut1 siRNA-treated RA synovial fibroblasts and control
siRNA-treated RA synovial fibroblasts. (B) RA synovial fibroblasts were first transfected with control or fut1 siRNA, and were grown on the top inserts.
Human dermal microvascular endothelial cells (HMVECs) were plated in the bottom of the wells of the transwell system for 24 hours. HMVECs were
plated on Matrigel with nontreated, control siRNA-transfected or fut1 siRNA-transfected RA synovial fibroblast-conditioned medium for 6 hours. A
representative photograph of HMVECs from co-culture with nontreated, control or fut1 siRNA-transfected RA synovial fibroblasts is shown. Arrows
indicate tubes. (C) HMVECs incubated with fut1 siRNA-transfected RA synovial fibroblast conditioned media formed significantly fewer tubes on
Matrigel compared with control siRNA-treated RA synovial fibroblasts or nontreated RA synovial fibroblasts. Means are presented with standard error of
the mean. *P <0.05 was significant (n = number of RA patient synovial fibroblasts).
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modified by covalently bound glycans, which are impor-
tant for physiological processes including protein folding,
degradation, signaling, and immune function [33]. The
complexity of the glycoproteome is thought to be several
orders of magnitude greater than the proteonome [33].
Human ABO blood group antigens and Lewis systems are
oligosaccharides synthesized by sequential actions of futs
and these antigens are important in blood typing [34]. The
α(1,2)-fucosyltransferases fut1 and fut2 are the enzymes
responsible for catalyzing an α(1,2)-linkage of fucose to
terminal beta galactosidase [35]. H and Lewis antigens are
expressed most abundantly in endodermal epithelial cells,
where the majority of human cancers arise [36].
We hypothesized that fut1 in RA is overexpressed, and
mediates angiogenesis, cell adhesion, and fibroblast pro-
liferation. Indeed, we found that α(1,2)-linked fucosy-
lated proteins were overexpressed in RA. Fucosylation is
one of the most common modifications involving oligo-
saccharides on glycoproteins, and their structures are in-
volved in a variety of biological processes in eukaryotic
organisms, angiogenesis, fertilization, cell adhesion, in-
flammation, and tumor metastasis [37]. We and others
have previously reported that sialyl Lewisx, synthesized
by α(1,3)-fucosyltransferases, is involved in angiogenesis
[21]. In addition, we reported that soluble H and Lewisy
antigens, both synthesized by fut1, are potent mediators
of cell adhesion, angiogenesis, and monocyte recruit-
ment [22,38,39]. Our study clearly demonstrates that
α(1,2)-linked fucosylated proteins are more highly ex-
pressed on RA synovial fibroblasts than on NL synovial
fibroblasts. Przybysz et al. showed that the expression of
α(1,6)-linked fucose in synovial fibronectins was related
to RA disease activity [40]. Kratz et al. showed that the
proportions of fucosyl determinants of intact synovial
IgA and IgG were lower in the early RA group compared
to the advanced RA group [41], suggesting that fuco-
sylated antibodies may be important in chronic RA
pathogenesis. These findings suggest that α(1,2)-linked
fucosylation has an important role in RA.
We next focused on fut1 expression and function in
RA tissues. Fut1 is overexpressed in some cancers such
as colon and pancreas. Fut1 mRNA in cancer tissues
was elevated compared to normal tissues [17,18]. Thus
far, there have been no reports of fut1 in RA. We exa-
mined a potential relationship between lining cells and
lining thickness score, however there was not a corre-
lation between them. Nonetheless, we and others have
shown that angiogenesis is important in the growth and
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Figure 4 Fucosyltransferase 1 (Fut1) siRNA inhibited pro-angiogenic mediator production in TNF-α-stimulated rheumatoid arthritis
(RA) synovial fibroblasts. (A) Monocyte chemoattract protein 1 (MCP-1/CCL2) mRNA expression in fut1 siRNA-treated RA synovial fibroblasts
was 60 ± 9% (mean ± standard error (SE)) of control siRNA-transfected RA synovial fibroblasts, showing a 40% reduction in MCP-1/CCL2 mRNA
expression in fut1 siRNA-transfected cells. (B) Epithelial-derived neutrophil-activating peptide 78 (ENA-78/CXCL5) mRNA expression in fut1
siRNA-treated RA synovial fibroblasts was 69 ± 11% (mean ± SE) of control siRNA transfected RA synovial fibroblasts, showing a 31% reduction
in ENA-78/CXCL5 mRNA expression fut1 siRNA-transfected cells. (C) Vascular endothelial growth factor (VEGF) mRNA expression in fut1 siRNA-treated
RA synovial fibroblasts was 79 ± 7% (mean ± SE) of control siRNA-transfected RA synovial fibroblasts, showing a 21% reduction in VEGF mRNA
expression fut1 siRNA-transfected cells. (D) Fut1 siRNA inhibited production of MCP-1/CCL2. (E) Fut1 siRNA inhibited production of ENA-78/CXCL5.
(F) Fut1 siRNA inhibited production of VEGF. Means are presented with SE. *P <0.05 was significant (n = number of RA patient synovial fibroblasts).
Isozaki et al. Arthritis Research & Therapy 2014, 16:R28 Page 9 of 14
http://arthritis-research.com/content/16/1/R28
proliferation of the RA ST pannus, and in the ingress of
leukocytes, and that cytokines play a key role in this
process [9,20,42]. We also found that HMVECs from a
co-culture system with fut1 siRNA-treated RA synovial
fibroblasts had decreased HMVEC tube formation com-
pared with HMVECs from a similar co-culture system
with control siRNA-treated or nontreated RA synovial
fibroblasts. This is in agreement with Mathieu et al. who
showed that fut1-deficient hepatocarcinoma cells had re-
duced angiogenic responses [43].
After defining the activity of fut1 using HMVEC tube
formation assays with RA synovial fibroblasts, we as-
sessed the expression of pro-angiogenic mediators from
fut1 siRNA-transfected RA synovial fibroblasts. We
found that MCP-1/CCL2, ENA-78/CXCL5, and VEGF
mRNA in TNF-α-stimulated fut1 siRNA-transfected RA
synovial fibroblasts were decreased compared to control
siRNA-transfected RA synovial fibroblasts. We also
found that secretion of MCP-1/CCL2, ENA-78/CXCL5,
and VEGF in TNF-α-stimulated fut1 siRNA-transfected
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Figure 5 Fucosyltransferase 1 (fut1) mediates adhesion of THP-1 cells to rheumatoid arthritis (RA) synovial fibroblasts and mediates
their proliferation. The percent adhesion was defined as the number of adherent cells on synovial tissue (ST) sections divided by the number of
adherent cells on control sections. (A) Adhesion of THP-1 cells to TNF-α-stimulated fut1 siRNA-transfected RA synovial fibroblasts (62 ± 8% of
maximal adhesion) was significantly decreased compared with adhesion of THP-1 cells to TNF-α-stimulated control siRNA-transfected (93 ± 8% of
maximal adhesion) or nontreated RA synovial fibroblasts. (B) Intercellular adhesion molecule 1 (ICAM-1) expression on TNF-α-stimulated fut1
siRNA-transfected RA synovial fibroblasts was significantly decreased compared to TNF-α-stimulated control siRNA or nontreated RA synovial
fibroblasts. (C) Vascular cell adhesion molecule 1 (VCAM-1) expression on TNF-α-stimulated fut1 siRNA-transfected RA synovial fibroblasts was
significantly decreased compared to TNF-α-stimulated control siRNA or nontreated RA synovial fibroblasts. (D) Fut1 siRNA-transfected lipolysaccharide
(LPS)-stimulated RA synovial fibroblasts showed reduced proliferation at 4 and 24 hours compared to LPS-stimulated control siRNA-transfected or
nontreated RA synovial fibroblasts. The results are shown as fold change in optical density of fut1- or control siRNA-transfected RA synovial fibroblasts
normalized to nontreated RA synovial fibroblasts. Means are presented with standard error. *P <0.05 was significant. (n = number of RA patient synovial
fibroblast cultures).
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Figure 6 Fucosyltransferase 1 (fut1) siRNA inhibits phosphorylated JNK signaling in rheumatoid arthritis (RA) synovial fibroblasts.
(A) Western blots were performed to determine whether TNF-α stimulates the phosphorylation of JNK. Phosphorylation of JNK signaling in
TNF-α-stimulated fut1 siRNA-transfected RA synovial fibroblasts was significantly decreased at 10 minutes compared to control siRNA-transfected
RA synovial fibroblasts. (B) Fut1 siRNA does not inhibit phosphorylation of NFκB, P38, and Erk1/2 in RA synovial fibroblasts. Means are presented
with standard errror. *P <0.05 was significant; *p indicates phosphorylated signaling proteins (n = number of RA patient synovial fibroblasts).
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RA synovial fibroblasts was decreased compared to con-
trol siRNA-transfected RA synovial fibroblasts. These
findings suggest that fut1 expressed in synovial fibro-
blasts is important in RA angiogenesis by contributing
to the production of pro-angiogenic mediators.
We next examined the role of fut1 in leukocyte adhe-
sion. Leukocyte retention in the synovium is an active
process mediated in part by cellular adhesion molecules
[44]. We found that adhesion of myeloid THP-1 cells to
fut1 siRNA-transfected RA synovial fibroblasts was
significantly decreased compared with control or non-
treated RA synovial fibroblasts. These findings are con-
sistent with Palumberi et al. who showed that adhesion
of human epidermoid carcinoma cells to fut1 and fut2
siRNA-transfected ECs was decreased compared with
control siRNA-transfected ECs [45]. On the other hand,
Kwiatkowski et al. reported that EC surface expression
of terminally sialylated structures by high-level fut1 ac-
tivity reduced monocyte adherence and activation [46].
However, this group did not examine which adhesion
molecules were differentially expressed during fut1 in-
hibition in ECs. In addition, the former group used bo-
vine post-capillary venular ECs that bind to epidermoid
carcinoma cells, while the other group used porcine EC
monolayers to examine monocyte adhesion. Perhaps the
different type of ECs, the use of epidermoid carcinoma
cells, along with the different cell isolation methods
could account for the differences in cellular adhesion. It
could also be that overexpression of futs may have
limits, and that highly elevated levels of fut activity may
actually inhibit monocyte and EC interactions, at least in
in vitro systems. Nonetheless, we found that cell-surface
adhesion molecules such as ICAM-1 or VCAM-1 on
fut1 siRNA-transfected RA synovial fibroblasts were
decreased compared to control fibroblasts. These fin-
dings indicate that fut1 in RA synovial fibroblasts is not
only important for cell adhesion, but indicate that these
interactions may also lead to activation of inflammatory
cells and perpetuation of inflammation in RA synovium.
RA synovial fibroblasts proliferate and invade cartilage
[47]. We found that fut1 siRNA inhibits cell proliferation
of LPS-stimulated RA synovial fibroblasts. Interestingly,
Palumberi et al. also reported that fut1 and fut2 siRNA-
treated human epidermoid carcinoma cells have reduced
cell proliferation when transfected with fut1 and fut2
siRNA [45]. In agreement with Palumberi, we found that
fut1 facilitates fibroblast proliferation, indicating that
α(1,2)-linked fucosylation by fut1 may contribute to
fibroblast overgrowth in the RA pannus.
Finally, we found that fut1 siRNA inhibited phosphory-
lated JNK signaling in RA synovial fibroblasts. On the
other hand, fut1 siRNA did not inhibit phosphorylation of
NFκB, P38, and Erk1/2 signaling in RA synovial fibro-
blasts. Overall, our results demonstrate that JNK plays key
roles in mediating angiogenesis, cell adhesion and RA syn-
ovial fibroblast proliferation through fut1.
Conclusion
Our study determined that α(1,2)-linked fucosylation of
fibroblasts is important in RA. We have shown that
α(1,2)-linked fucosylated proteins are highly expressed in
RA synovial fibroblasts compared to NL synovial fibro-
blasts. We also have demonstrated that fut1 is expressed
on RA synovial lining cells and macrophages. Most im-
portantly, we have shown that fut1 in RA synovial fibro-
blasts contributes to angiogenesis, cell adhesion, and cell
proliferation. We propose that fut1 plays roles in mediat-
ing arthritis by this multistep process. Taken together,
these results demonstrate the importance of α(1,2)-linked
fucosylation by fut1 in RA and suggest that targeting fut1
may be important in combating RA.
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